Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Pre-Tax Income
Glenmark Life Sciences Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Pre-Tax Income
₹6.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Pre-Tax Income
₹72B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Pre-Tax Income
₹57B
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Pre-Tax Income
₹105.1B
|
CAGR 3-Years
62%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Pre-Tax Income
₹37.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
8%
|
CAGR 10-Years
16%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Pre-Tax Income
₹21.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
See Also
What is Glenmark Life Sciences Ltd's Pre-Tax Income?
Pre-Tax Income
6.3B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Pre-Tax Income amounts to 6.3B INR.
What is Glenmark Life Sciences Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
23%
Over the last year, the Pre-Tax Income growth was 0%. The average annual Pre-Tax Income growth rates for Glenmark Life Sciences Ltd have been 10% over the past three years , 23% over the past five years .